Skip to main content

49 publications

Name Date Type Actions

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (23 au 27 mai 2016) (french)

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

30/05/2016 Monthly communication regarding buyback programs

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mai au 3 juin 2016) - french

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

06/06/2016 Monthly communication regarding buyback programs

Programme de rachat - mai 2016 - french

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

06/06/2016 Monthly communication regarding buyback programs

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (20 au 24 juin 2016)

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

01/07/2016 Monthly communication regarding buyback programs

Dynamic first half 2016

2016 Half year Financial Report

28/07/2016 Public releases

Communiqué de mise à disposition du rapport financier semestriel relatif à l’exercice 2016 (french)

Communiqué de mise à disposition  du rapport financier semestriel relatif à l’exercice 2016 

28/07/2016 Public releases

Vetoquinol launches its employer brand

The veterinary pharmaceutical company Vetoquinol launches its employer brand. For 83 years, Vetoquinol has been building its future, drawing on relationships of trust with its partners, the development of every employee, and its long-held belief of continuous improvement. Following on from its corporate brand, the company is now positioning itself as a high-quality employer.

29/09/2016 Public releases

September 2016 year-to-date sales: €257.5 million a 4.8% organic growth

Vetoquinol posted sales of €257.5 million for the first nine months of 2016, up 2.3% compared to the same period last year. Organic growth for the period came to 4.8%, curbed by a 2.5% negative currency impact. 

18/10/2016 Public releases

2015 sales up 8.7% to €342.6 million

The Vetoquinol Group posted 2015 sales of €342.6 million, up 8.7% on reported data and up 3.8% at constant exchange rates. The Group benefited from a positive currency impact of 4.9% mainly linked to the US dollar, Indian rupee and British pound.

08/02/2016 Public releases

2015 results sales of reference products up 9.4% ebit up 10.3%

At its meeting on March 18, 2016, the Vetoquinol S.A. Board of Directors reviewed the Group’s results and approved the 2015 financial statements.

21/03/2016 Public releases